Back to search results

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Israel
RecruitingPHASE1

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Pancreatic Ductal Adenocarcinoma · Non-Small Cell Lung Cancer · HR+/HER2- Ductal and Lobular Breast Cancer · Triple Negative Breast Cancer · Colorectal Cancer · Soft Tissue Sarcoma

Locations
  • Novartis Investigative Site, Montreal, Quebec, Canada
  • Novartis Investigative Site, Vandœuvre-lès-Nancy, France
  • Novartis Investigative Site, Haifa, Israel
  • Novartis Investigative Site, Tel Aviv, Israel
  • Novartis Investigative Site, Singapore, Singapore
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)